Single-cell, phosphoepitope-specific analysis demonstrates cell type-and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection

Journal of Virology

Volumn 82, Issue 7, 2008, Pages 3702-3712

  Lee, Andrew W ^a,e   Sharp, Elizabeth R ^b   O'Mahony, Alison ^b   Rosenberg, Michael G ^c   Israelski, Dennis M ^a,d   Nolan, Garry P ^a   Nixon, Douglas F ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d San Mateo County Mental Health Services   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; JANUS KINASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; STAT5 PROTEIN;

ADOLESCENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL TYPE; CHILD; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOCOMPETENT CELL; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; VIRUS LOAD;

ADOLESCENT; ANTIGENS, SURFACE; CD4 LYMPHOCYTE COUNT; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; MONOCYTES; PHOSPHORYLATION; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 41149124865     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01582-07     Document Type: Article

References (44)

1. + T-cell homeostasis and function in advanced HIV disease. Science 277:112-116.
2. Balasubramanian, A., R. K. Ganju, and J. E. Groopman. 2006. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. J. Infect. Dis. 194:670-681.
3. Beignon, A. S., K. McKenna, M. Skoberne, O. Manches, I. DaSilva, D. G. Kavanagh, M. Larsson, R. J. Gorelick, J. D. Lifson, and N. Bhardwaj. 2005. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Investig. 115:3265-3275.
4. Bovolenta, C., L. Camorali, A. L. Lorini, S. Ghezzi, E. Vicenzi, A. Lazzarin, and G. Poli. 1999. Constitutive activation of STATs upon in vivo human immunodeficiency virus infection. Blood 94:4202-4209.
5. Breen, E. C., A. R. Rezai, K. Nakajima, G. N. Beall, R. T. Mitsuyasu, T. Hirano, T. Kishimoto, and O. Martinez-Maza. 1990. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 144:480-484.
6. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bernstein, O. Lambotte, D. Altmann, B. R. Blazar, B. Rodriguez, L. Teixeira-Johnson, A. Landay, J. N. Martin, F. M. Hecht, L. J. Picker, M. M. Lederman, S. G. Deeks, and D. C. Douek. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371.
7. Brites, C., M. J. Gilbert, D. Pedral-Sampaio, F. Bahia, C. Pedroso, A. P. Alcantara, M. D. Sasaki, J. Matos, B. Renjifo, M. Essex, J. B. Whitmore, J. M. Agosti, and R. Badaro. 2000. A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS. J. Infect. Dis. 182:1531-1535.
8. Cicala, C., J. Arthos, S. M. Selig, G. Dennis, Jr., D. A. Hosack, D. Van Ryk, M. L. Spangler, T. D. Steenbeke, P. Khazanie, N. Gupta, J. Yang, M. Daucher, R. A. Lempicki, and A. S. Fauci. 2002. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc. Natl. Acad. Sci. USA 99:9380-9385.
9. Crocker, P. R., J. C. Paulson, and A. Varki. 2007. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7:255-266.
10. Crotti, A., M. Lusic, R. Lupo, P. M. Lievens, E. Liboi, G. D. Chiara, M. Tinelli, A. Lazzarin, B. K. Patterson, M. Giacca, C. Bovolenta, and G. Poli. 2007. Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression. Blood 109:5380-5389.
11. Crowe, S. M., and A. Lopez. 1997. GM-CSF and its effects on replication of HIV-1 in cells of macrophage lineage. J. Leukoc. Biol. 62:41-48.
12. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
13. de Groot, R. P., P. J. Coffer, and L. Koenderman. 1998. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal. 10:619-628.
14. Dupuis, S., E. Jouanguy, S. Al-Hajjar, C. Fieschi, I. Z. Al-Mohsen, S. Al-Jumaah, K. Yang, A. Chapgier, C. Eidenschenk, P. Eid, A. Al Ghonaium, H. Tufenkeji, H. Frayha, S. Al-Gazlan, H. Al-Rayes, R. D. Schreiber, I. Gresser, and J. L. Casanova. 2003. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33:388-391.
15. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95:14863-14868.
16. + monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178:6581-6589.
17. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya, and A. Yoshimura. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924.
18. He, X. S., X. Ji, M. B. Hale, R. Cheung, A. Ahmed, Y. Guo, G. P. Nolan, L. M. Pfeffer, T. L. Wright, N. Risch, R. Tibshirani, and H. B. Greenberg. 2006. Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology 44:352-359.
19. Irish, J. M., N. Anensen, R. Hovland, J. Skavland, A. L. Borresen-Dale, O. Bruserud, G. P. Nolan, and B. T. Gjertsen. 2007. Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53. Blood 109:2589-2596.
20. Irish, J. M., D. K. Czerwinski, G. P. Nolan, and R. Levy. 2006. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood 108:3135-3142.
21. Irish, J. M., R. Hovland, P. O. Krutzik, O. D. Perez, O. Bruserud, B. T. Gjertsen, and G. P. Nolan. 2004. Single cell profiling of potentiated phosphoprotein networks in cancer cells. Cell 118:217-228.
22. Irish, J. M., N. Kotecha, and G. P. Nolan. 2006. Mapping normal and cancer cell signalling networks: toward single-cell proteomics. Nat. Rev. Cancer 6:146-155.
23. + lymphocyte counts in patients with uncontrolled HIV infection. J. Infect. Dis. 188:1804-1814.
24. + cells of lymphocyte or monocyte/macrophage lineages. J. Leukoc. Biol. 73:407-416.
25. Krutzik, P. O., J. M. Irish, G. P. Nolan, and O. D. Perez. 2004. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin. Immunol. 110:206-221.
26. Kryworuchko, M., V. Pasquier, H. Keller, D. David, C. Goujard, J. Gilquin, J. P. Viard, M. Joussemet, J. F. Delfraissy, and J. Theze. 2004. Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy. AIDS 18:421-426.
27. Lee, C., B. Tomkowicz, B. D. Freedman, and R. G. Collman. 2005. HIV-1 gp120-induced TNF-α production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways. J. Leukoc. Biol. 78:1016-1023.
28. Meier, A., G. Alter, N. Frahm, H. Sidhu, B. Li, A. Bagchi, N. Teigen, H. Streeck, H. J. Stellbrink, J. Hellman, J. van Lunzen, and M. Altfeld. 2007. MyD88-dependent immune activation mediated by HIV-1-encoded TLR ligands. J. Virol. 81:8180-8191.
29. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and T. Kishimoto. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924-929.
30. Ott, M., S. Emiliani, C. Van Lint, G. Herbein, J. Lovett, N. Chirmule, T. McCloskey, S. Pahwa, and E. Verdin. 1997. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275:1481-1485.
31. Paukku, K., and O. Silvennoinen. 2004. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine Growth Factor Rev. 15:435-455.
32. Qiao, X., B. He, A. Chiu, D. M. Knowles, A. Chadburn, and A. Cerutti. 2006. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol. 7:302-310.
33. Schrager, J. A., V. Der Minassian, and J. W. Marsh. 2002. HIV Nef increases T-cell ERK MAP kinase activity. J. Biol. Chem. 277:6137-6142.
34. Selliah, N., M. Zhang, D. DeSimone, H. Kim, M. Brunner, R. F. Ittenbach, H. Rui, R. Q. Cron, and T. H. Finkel. 2006. The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells. Virology 344:283-291.
35. Sharp, E. R., J. D. Barbour, R. K. Karlsson, K. A. Jordan, J. K. Sandberg, A. Wiznia, M. G. Rosenberg, and D. F. Nixon. 2005. Higher frequency of HIV-1-specific T-cell immune responses in African American children vertically infected with HIV-1. J. Infect. Dis. 192:1772-1780.
36. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921.
37. Tomkowicz, B., C. Lee, V. Ravyn, R. Cheung, A. Ptasznik, and R. G. Collman. 2006. The Src kinase Lyn is required for CCR5 signaling in response to MIP-1β and R5 HIV-1 gp120 in human macrophages. Blood 108:1145-1150.
38. Toschi, E., I. Bacigalupo, R. Strippoli, C. Chiozzini, A. Cereseto, M. Falchi, F. Nappi, C. Sgadari, G. Barillari, F. Mainiero, and B. Ensoli. 2006. HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. Mol. Biol. Cell 17:1985-1994.
39. Trial, J., H. H. Birdsall, J. A. Hallum, M. L. Crane, M. C. Rodriguez-Barradas, A. L. de Jong, B. Krishnan, C. E. Lacke, C. G. Figdor, and R. D. Rossen. 1995. Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection: effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype. J. Clin. Investig. 95:1690-1701.
40. Trinchieri, G., and A. Sher. 2007. Cooperation of Toll-like receptor signals in innate immune defense. Nat. Rev. Immunol. 7:179-190.
41. Trushin, S. A., A. Algeciras-Schimnich, S. R. Vlahakis, G. D. Bren, S. Warren, D. J. Schnepple, and A. D. Badley. 2007. Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T-cell death that is facilitated by, but does not require cell-associated CD4. J. Immunol. 178:4846-4853.
42. Wang, J., G. Roderiquez, T. Oravecz, and M. A. Norcross. 1998. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J. Virol. 72:7642-7647.
43. Warby, T. J., S. M. Crowe, and A. Jaworowski. 2003. Human immunodeficiency virus type 1 infection inhibits granulocyte-macrophage colony-stimulating factor-induced activation of STAT5A in human monocyte-derived macrophages. J. Virol. 77:12630-12638.
44. Yang, X., and D. Gabuzda. 1999. Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J. Virol. 73:3460-3466.